機械血栓切除設備市場規模、佔有率和成長分析（按產品類型、應用、最終用戶和地區）- 產業預測 2025-2032

2023 年全球機械血栓切除設備市場規模價值 16.5 億美元，預計將從 2024 年的 17.7 億美元成長到 2032 年的 30.6 億美元，預測期內（2025-2032 年）的複合年成長率為 7.1%。

受中風和血管疾病發病率上升的推動，全球機械血栓切除設備市場正在經歷強勁成長。這一趨勢與醫療行業對微創手術的日益偏好相吻合，將機械血栓切除術定位為治療血栓引起的缺血性中風的傳統手術方法的首選替代方案。患者和醫療保健提供者正在優先考慮能夠最大程度減少創傷和恢復時間同時改善治療效果的治療方案，從而推動這些設備的採用。技術進步、人口老化和醫療保健基礎設施改善等因素進一步推動了市場擴張。儘管主要企業正在積極尋求產品創新和合作夥伴關係以站穩腳跟，但成本限制和區域認可有限等挑戰仍然存在。對有效清除血栓解決方案的需求表明市場將持續成長。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 技術進步
• 監管格局
• 專利分析

機械血栓切除設備市場規模（依產品類型及複合年成長率）（2025-2032）

• 市場概況
• 吸痰管
• 線圈回收器
• 支架回收裝置
• 其他設備

機械血栓切除設備市場規模（按應用分類）及複合年成長率（2025-2032）

• 市場概況
• 缺血性中風
• 肺動脈栓塞（PE）
• 深層靜脈栓塞症（DVT）

機械血栓切除設備市場規模（按最終用戶和複合年成長率分類）（2025-2032）

• 市場概況
• 醫院
• 門診手術中心
• 專科門診

機械血栓切除設備市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Medtronic plc（Ireland）
• Stryker Corporation（USA）
• Penumbra, Inc.（USA）
• Boston Scientific Corporation（USA）
• Terumo Corporation（Japan）
• Johnson & Johnson（USA）
• Abbott Laboratories（USA）
• Becton, Dickinson and Company（USA）
• Teleflex Incorporated（USA）
• AngioDynamics, Inc.（USA）
• Merit Medical Systems, Inc.（USA）
• Edwards Lifesciences Corporation（USA）
• Cook Medical（USA）
• Acandis GmbH（Germany）
• Phenox GmbH（Germany）
• MicroVention, Inc.（USA）
• Rapid Medical（Israel）
• Vesalio（USA）
• Inari Medical, Inc.（USA）
• Balt USA LLC（USA）

結論和建議

Global Mechanical Thrombectomy Devices Market size was valued at USD 1.65 billion in 2023 and is poised to grow from USD 1.77 billion in 2024 to USD 3.06 billion by 2032, growing at a CAGR of 7.1% during the forecast period (2025-2032).

The global market for mechanical thrombectomy devices is experiencing robust growth, driven by the rising incidence of strokes and vascular diseases. This trend aligns with the healthcare industry's increasing preference for minimally invasive procedures, positioning mechanical thrombectomy as a favorable alternative to traditional surgical approaches for treating ischemic strokes caused by blood clots. Patients and providers prioritize treatment options that minimize trauma and recovery time while enhancing outcomes, bolstering the adoption of these devices. Factors such as technological advancements, an aging population, and improved healthcare infrastructure further fuel market expansion. Key players are actively pursuing product innovation and collaborations to strengthen their foothold, though challenges such as cost constraints and limited regional awareness persist. The demand for effective clot removal solutions suggests continued market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Mechanical Thrombectomy Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Mechanical Thrombectomy Devices Market Segments Analysis

Global Mechanical Thrombectomy Devices Market is segmented by Product Type, Application, End-user and region. Based on Product Type, the market is segmented into Aspiration Catheters, Coil Retrievers, Stent Retrievers, and Other Devices. Based on Application, the market is segmented into Ischemic Stroke, Pulmonary Embolism (PE) and Deep Vein Thrombosis (DVT). Based on End-user, the market is segmented into Hospitals, Ambulatory Surgical Centers and Specialty Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Mechanical Thrombectomy Devices Market

The growth of the global mechanical thrombectomy devices market is primarily fueled by the increasing prevalence of strokes, especially ischemic strokes. These devices play a crucial role in efficiently extracting blood clots from obstructed arteries, subsequently lowering the chances of disability and mortality linked to strokes. With an aging global population and a rise in risk factors like hypertension, diabetes, and obesity, there is an anticipated surge in the demand for mechanical thrombectomy procedures. This trend underscores the urgent need for advanced medical technologies to address the escalating challenges posed by stroke-related health issues.

Restraints in the Global Mechanical Thrombectomy Devices Market

The Global Mechanical Thrombectomy Devices market faces notable restraints primarily due to the high costs associated with both the devices and the procedures themselves. The financial burden, which includes expenses for hospitalization and post-operative care, can deter health systems, insurance providers, and patients from embracing these technologies. This economic challenge may hinder broader acceptance and utilization of mechanical thrombectomy devices, as the potential for significant out-of-pocket expenses poses a substantial barrier to access. Consequently, the overall growth and adoption of mechanical thrombectomy solutions may be restricted as stakeholders navigate these financial concerns.

Market Trends of the Global Mechanical Thrombectomy Devices Market

The Global Mechanical Thrombectomy Devices market is witnessing a dynamic trend characterized by rapid technological advancements and innovative product development. Manufacturers are increasingly focusing on creating highly efficient and precise devices that prioritize minimally invasive procedures for clot removal. This trend involves significant improvements in device design and imaging technologies, along with the integration of robotic systems and navigation technologies, aimed at enhancing procedural effectiveness and patient safety. These innovations not only improve clinical outcomes but also drive market growth as healthcare providers seek more sophisticated solutions to address the challenges of thromboembolic events, thus shaping the future landscape of the industry.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Advancement
• Regulatory Landscape
• Patent Analysis

Global Mechanical Thrombectomy Devices Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Aspiration Catheters
• Coil Retrievers
• Stent Retrievers
• Other Devices

Global Mechanical Thrombectomy Devices Market Size by Application & CAGR (2025-2032)

• Market Overview
• Ischemic Stroke
• Pulmonary Embolism (PE)
• Deep Vein Thrombosis (DVT)

Global Mechanical Thrombectomy Devices Market Size by End-user & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

Global Mechanical Thrombectomy Devices Market Size & CAGR (2025-2032)

• North America (Product Type, Application, End-user)
  • US
  • Canada
• Europe (Product Type, Application, End-user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application, End-user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application, End-user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, End-user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Penumbra, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acandis GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phenox GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroVention, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rapid Medical (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vesalio (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inari Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Balt USA LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations